163 related articles for article (PubMed ID: 8077664)
1. Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum merozoite surface protein 1 (MSP1), YMSP1(19) expressed in S. cerevisiae.
Hui GS; Gosnell WL; Case SE; Hashiro C; Nikaido C; Hashimoto A; Kaslow DC
J Immunol; 1994 Sep; 153(6):2544-53. PubMed ID: 8077664
[TBL] [Abstract][Full Text] [Related]
2. Induction of antibodies to the Plasmodium falciparum merozoite surface protein-1 (MSP1) by cross-priming with heterologous MSP1s.
Hui GS; Hashimoto AC; Nikaido CM; Choi J; Chang SP
J Immunol; 1994 Aug; 153(3):1195-201. PubMed ID: 8027549
[TBL] [Abstract][Full Text] [Related]
3. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth.
Chang SP; Gibson HL; Lee-Ng CT; Barr PJ; Hui GS
J Immunol; 1992 Jul; 149(2):548-55. PubMed ID: 1624802
[TBL] [Abstract][Full Text] [Related]
4. Regulation of antibody specificity to Plasmodium falciparum merozoite surface protein-1 by adjuvant and MHC haplotype.
Chang SP; Nikaido CM; Hashimoto AC; Hashiro CQ; Yokota BT; Hui GS
J Immunol; 1994 Apr; 152(7):3483-90. PubMed ID: 8144929
[TBL] [Abstract][Full Text] [Related]
5. Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus.
Hui GS; Hashiro C; Nikaido C; Case SE; Hashimoto A; Gibson H; Barr PJ; Chang SP
Infect Immun; 1993 Aug; 61(8):3403-11. PubMed ID: 7687586
[TBL] [Abstract][Full Text] [Related]
6. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
[TBL] [Abstract][Full Text] [Related]
7. Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: implications for vaccine development.
Yuen D; Leung WH; Cheung R; Hashimoto C; Ng SF; Ho W; Hui G
Vaccine; 2007 Jan; 25(3):490-9. PubMed ID: 16949181
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium falciparum anti-MSP1-19 antibodies induced by MSP1-42 and MSP1-19 based vaccines differed in specificity and parasite growth inhibition in terms of recognition of conserved versus variant epitopes.
Hui G; Hashimoto C
Vaccine; 2007 Jan; 25(5):948-56. PubMed ID: 17023096
[TBL] [Abstract][Full Text] [Related]
9. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
Bargieri DY; Leite JA; Lopes SC; Sbrogio-Almeida ME; Braga CJ; Ferreira LC; Soares IS; Costa FT; Rodrigues MM
Vaccine; 2010 Apr; 28(16):2818-26. PubMed ID: 20170765
[TBL] [Abstract][Full Text] [Related]
10. Anti-MSP1 block 2 antibodies are effective at parasite killing in an allele-specific manner by monocyte-mediated antibody-dependent cellular inhibition.
Galamo CD; Jafarshad A; Blanc C; Druilhe P
J Infect Dis; 2009 Apr; 199(8):1151-4. PubMed ID: 19284307
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-1(42) using human compatible adjuvants.
Sachdeva S; Mohmmed A; Dasaradhi PV; Crabb BS; Katyal A; Malhotra P; Chauhan VS
Vaccine; 2006 Mar; 24(12):2007-16. PubMed ID: 16377036
[TBL] [Abstract][Full Text] [Related]
12. [Humoral immune response in mice to hybrid nucleic acid vaccines containing Plasmodium falciparum merozoite surface protein 1 block 17-based gene].
Miao J; Li X; Xue C; Zhen R; Liu Z; Qin E; Yu Q
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(5):302-4. PubMed ID: 12563865
[TBL] [Abstract][Full Text] [Related]
13. Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine.
Tian JH; Miller LH; Kaslow DC; Ahlers J; Good MF; Alling DW; Berzofsky JA; Kumar S
J Immunol; 1996 Aug; 157(3):1176-83. PubMed ID: 8757623
[TBL] [Abstract][Full Text] [Related]
14. Analysis of immunological nonresponsiveness to the 19-kilodalton fragment of merozoite surface Protein 1 of Plasmodium yoelii: rescue by chemical conjugation to diphtheria toxoid (DT) and enhancement of immunogenicity by prior DT vaccination.
Stanisic DI; Martin LB; Liu XQ; Jackson D; Cooper J; Good MF
Infect Immun; 2003 Oct; 71(10):5700-13. PubMed ID: 14500491
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys.
Pichyangkul S; Tongtawe P; Kum-Arb U; Yongvanitchit K; Gettayacamin M; Hollingdale MR; Limsalakpetch A; Stewart VA; Lanar DE; Dutta S; Angov E; Ware LA; Bergmann-Leitner ES; House B; Voss G; Dubois MC; Cohen JD; Fukuda MM; Heppner DG; Miller RS
Vaccine; 2009 Dec; 28(2):452-62. PubMed ID: 19857448
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175.
Sim BK; Carter JM; Deal CD; Holland C; Haynes JD; Gross M
Exp Parasitol; 1994 May; 78(3):259-68. PubMed ID: 7512929
[TBL] [Abstract][Full Text] [Related]
17. "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide.
Kumar A; Arora R; Kaur P; Chauhan VS; Sharma P
J Immunol; 1992 Mar; 148(5):1499-505. PubMed ID: 1371529
[TBL] [Abstract][Full Text] [Related]
18. Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant.
Xue X; Ding F; Zhang Q; Pan X; Qu L; Pan W
Vaccine; 2010 Apr; 28(18):3152-8. PubMed ID: 20197139
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies.
Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ
Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663
[TBL] [Abstract][Full Text] [Related]
20. Synthetic peptides from P. falciparum sexual stage 25-kDa protein induce antibodies that react with the native protein: the role of IL-2 and conformational structure on immunogenicity of Pfs25.
Quakyi IA; Miller LH; Good MF; Ahlers JD; Isaacs SN; Nunberg JH; Houghten RA; Keister DB; Coligan JE; Moss B
Pept Res; 1995; 8(6):335-44. PubMed ID: 8838417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
